You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Giapreza

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Septic Shock, Shock, Sepsis Trial (Angiotensin II and hydrocortisone sodium succinate)

Not yet recruiting
  • Septic Shock
  • +3 more
  • Angiotensin II and hydrocortisone sodium succinate
  • (no location specified)
Nov 3, 2023

Distributive Shock Trial in Chicago (Angiotensin II, Placebo)

Not yet recruiting
  • Distributive Shock
  • Angiotensin II
  • Placebo
  • Chicago, Illinois
    Northwestern University
Feb 13, 2022

Septic Shock, Vasodilatory Shock Trial in Albuquerque (Angiotensin II)

Recruiting
  • Septic Shock
  • Vasodilatory Shock
  • Angiotensin II
  • Albuquerque, New Mexico
    University of New Mexico Health Sciences Center
Apr 19, 2023

Liver Transplant; Complications, Vasoplegia Trial in San Francisco (Angiotensin II, Saline)

Recruiting
  • Liver Transplant; Complications
  • Vasoplegia
  • San Francisco, California
    University of California, San Francisco
Jun 29, 2022

Septic Shock Trial in Albuquerque (Angiotensin II, Vasopressin)

Not yet recruiting
  • Septic Shock
  • Albuquerque, New Mexico
    University of New Mexico Health Sciences Center
Jan 2, 2022

Hepatorenal Syndrome, Cirrhosis, Kidney Failure, Acute Trial (Angiotensin II, Midodrine, Octreotide)

Not yet recruiting
  • Hepatorenal Syndrome
  • +2 more
  • Angiotensin II
  • +3 more
  • (no location specified)
Sep 9, 2020

Shock, Surgical, Shock, Hypotension and Shock Trial in Chicago (Angiotensin II)

Completed
  • Shock, Surgical
  • +5 more
  • Angiotensin II
  • Chicago, Illinois
    University of Illinois Hospital and Health Sciences System
Aug 13, 2021

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

Diabetes Trial in Boston (Para-aminohippuric Acid, Angiotensin II, Norepinephrine)

Terminated
  • Diabetes Mellitus
  • Para-aminohippuric Acid
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital- 221 Longwood Avenue
Nov 7, 2022

Septic Shock, Acute Kidney Injury Trial in Lexington (Standard of Care, Angiotensin II)

Recruiting
  • Septic Shock
  • Acute Kidney Injury
  • Standard of Care
  • Angiotensin II
  • Lexington, Kentucky
    University of Kentucky HealthCare Chandler Medical Center
Dec 7, 2022

Angiotensin-Dependent Arterial and Renal Vasoconstriction in

Recruiting
  • Hormone Therapy
  • Angiotensin II
  • Calgary, Alberta, Canada
    University of Calgary
Jun 28, 2022

Hypertension, Insulin Resistance Trial in Boston (Para-aminohippuric Acid, Angiotensin II, Norepinephrine)

Active, not recruiting
  • Hypertension
  • Insulin Resistance
  • Para-aminohippuric Acid
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 28, 2022

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers

Recruiting
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
  • PCP
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

Recruiting
  • COVID-19
  • Cardiovascular Diseases
  • Angiotensin converting enzyme inhibitor
  • Angiotensin II Receptor Blockers
  • Maceio, Alagoas, Brazil
  • +30 more
Jan 13, 2023

Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury Trial in Los Angeles (Angiotensin II, Norepinephrine)

Enrolling by invitation
  • Cirrhosis, Liver
  • +3 more
  • Los Angeles, California
    Michael Y Lin
Jun 10, 2022

Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in United States (drug, behavioral, other)

Completed
  • Cognitively Normal Older Adults
  • +3 more
  • Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
  • +3 more
  • Kansas City, Kansas
  • +3 more
Feb 12, 2022

Hypertension Trial in Boston (Para-aminohippuric Acid, Angiotensin II, Norepinephrine)

Terminated
  • Hypertension
  • Para-aminohippuric Acid
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
May 10, 2021

Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,

Completed
  • Idiopathic Membranous Nephropathy
  • symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
  • experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
  • Paris, France
    Department of Nephrology , Tenon hospital - APHP
Oct 18, 2021

STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)

Not yet recruiting
  • STEMI - ST Elevation Myocardial Infarction
  • Left Ventricular Systolic Dysfunction
  • Dapagliflozin 10Mg Tab
  • Placebo
  • (no location specified)
Sep 6, 2021

Coronavirus Disease(COVID)-19 Acute Respiratory Distress

Recruiting
  • COVID
  • Acute Respiratory Distress Syndrome
  • Angiotensin II
  • Interleukin-1 receptor antagonist
  • London, United Kingdom
    Guy's & St Thomas' Hospital
Aug 3, 2021

COPD, Pulmonary Artery Hypertension, Heart Failure Trial in Salt Lake City (Maximum Exercise Tests, BH4, L-NMMA, Vitamin C,

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • +3 more
  • Maximum Exercise Tests
  • +6 more
  • Salt Lake City, Utah
    George E Wahlen VA Medical Center
Sep 15, 2021

Coronavirus Disease 2019 Patients Receiving Receiving

Completed
  • COVID-19
  • Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Centre
Aug 1, 2020

Hypertension, Dyslipidemias Trial in Seoul (Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination)), Two separated

Completed
  • Hypertension
  • Dyslipidemias
  • Olostar Tab (olmesartan/rosuvastatin FDC(fixed dose combination))
  • Two separated drugs(ARB(Angiotensin Ⅱ receptor blocker) and statin)
  • Seoul, Korea, Republic of
    Division of Cardiology, Severance Cardiovascular Hospital, Yonse
Aug 19, 2019

Hypertension Trial in Dallas (Metoprolol succinate, Nebivolol, Forearm blood flow)

Completed
Has Results
  • Hypertension
  • Metoprolol succinate
  • +6 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jul 3, 2020

Septic Shock Trial in Cairo (Angiotensin II, Normal saline, Norepinephrine)

Suspended
  • Septic Shock
  • Angiotensin II
  • +2 more
  • Cairo, Egypt
    Cairo University
Jan 14, 2019